ABSTRACT
The MNa (in vitro the micronucleus assay) is recommended for studying genotoxicity of chemicals. However, no protocol is currently available for experiments with mouse fibroblast L929 cells. The aim of this study was to improve the scope of CBMNb (cytokinesis-block micronucleus) test. Optimization consisted of: selection of a non-cytotoxic concentration of cytokinesis blocker - cytoBc (cytochalasin B) and type and definition of the positive controls, verification of the efficacy of phenobarbital/5,6-benzoflavone as an S9 enzyme inducer as well as the identification of an optimal staining method. The compounds were tested in three exposure regimens: 6 h exposure with S9 activation followed by a 24 h recovery period, 6 h exposure followed by a 24 h recovery without metabolic activation of S9 and 30 h continuous exposure without S9. Different parameters, such as internal and interlaboratory reproducibility were investigated and criteria for test correctness were proposed. Higher MN rates were achieved using 1 µg/mL cytoBc as a cytokinesis blocker, and MMSd (methyl methanesulfonate), (250 µM), Cole (colchicine), (0.5 µM) and CPf (cyclophosphamide), (30 µM) as positive controls. In regard to the recommended S9 inducer, phenobarbital/5,6-benzoflavone was more effective as Aroclor 1254. Giemsa and acridine orange stains were optimal for the evaluation of MN formation. The protocol described in this study with L929 cells produced the reliable results and is suitable for performing the CBMNb experiments according to the current OECD Guideline #487.
Subject(s)
Fibroblasts/drug effects , Mutagens/toxicity , Activation, Metabolic/drug effects , Animals , Cell Line , Colchicine/toxicity , Cyclophosphamide/toxicity , Cytochalasin B/toxicity , Cytokinesis/drug effects , Methyl Methanesulfonate/toxicity , Mice , Micronucleus Tests/methods , Reproducibility of ResultsABSTRACT
Fifty-seven compounds were purified from the stems of Tinospora sinensis, including three new compounds characterized as a lignan (1), a pyrrole alkaloid (11), and a benzenoid (17), respectively. Their structures were elucidated and established by various spectroscopic and spectrometric analytical methods. Among the isolates, fifteen compounds were examined for their anti-inflammatory potential in vitro. The results showed that several compounds displayed moderate inhibition of N-formyl-methionyl-leucyl-phenylalanine/cytochalasin B (fMLP/CB)-induced superoxide anion generation and elastase release.
Subject(s)
Alkaloids/pharmacology , Lignans/pharmacology , Pancreatic Elastase/metabolism , Pyrroles/pharmacology , Alkaloids/chemistry , Cytochalasin B/antagonists & inhibitors , Cytochalasin B/toxicity , Humans , Lignans/chemistry , Molecular Structure , Neutrophils/drug effects , Neutrophils/enzymology , Pancreatic Elastase/biosynthesis , Pancreatic Elastase/drug effects , Plant Stems/chemistry , Pyrroles/chemistry , Superoxides/antagonists & inhibitors , Superoxides/toxicity , Tinospora/chemistryABSTRACT
We investigated the commercially available Episkin LM™ reconstructed epidermis test system as a potential 3D model for human genotoxicity assessment by cytokinesis-block micronucleus assay to mitigate limitations of the currently accepted micronucleus test. We established appropriate culture conditions for cytokinesis-block micronucleus assay in maximizing the frequency of binucleated cells by choice of culture medium and calibration of the system exposure to the cytokinesis inhibitor Cytochalasin B, without affecting the basal frequency of micronuclei in the model. We confirmed that the application of the classic solvents had no significant effect on this basal level of micronuclei. We determined the performance of cytokinesis-block micronucleus assay in Episkin LM™ reconstructed epidermis to predict in vivo genotoxins by testing the genotoxicity potential of 17 well known in vivo genotoxic, progenotoxic and non-genotoxic reference chemicals over a 48â¯h and 72â¯h exposure period. We found that cytokinesis-block micronucleus assays in Episkin™ reconstructed epidermis following the 48 h-topical regimen had a specificity of 60-75% and a sensitivity of 83-85%, resulting in an overall accuracy of 76-82% for genotoxicity assessment in tissues depending on the assessment of the reference chemicals with equivocal genotoxic profiles in the literature. The positive micronucleus test results obtained without addition of any exogenous metabolic activation system confirmed the ability of Episkin LM™ reconstructed epidermis to intrinsically bioactivate progenotoxic chemicals. The evidence showed that the 72-h exposure protocol significantly improved the detection of progenotoxins. Taken together, our data demonstrated that the Episkin LM™ reconstructed epidermis system is a relevant in vitro tool in the study of genetic toxicology.
Subject(s)
Cytochalasin B/toxicity , Cytokinesis/drug effects , Epidermal Cells/cytology , Activation, Metabolic/drug effects , Cells, Cultured , Humans , Micronucleus Tests , Models, BiologicalABSTRACT
Endophytic fungi are fungi that colonize internal tissues of plants; several biologically active compounds have been isolated from these fungi. There are few studies of compounds isolated from endophytic fungi of Amazon plants. Thus, this study aimed the isolation and structural identification of ergosterol (1), ergosterol peroxide (2), mevalonolactone (3), cytochalasin B (4) and cytochalasin H (5) from Aspergillus sp. EJC 04, an endophytic fungus from Bauhinia guianensis. The cytochalasin B (4) and the diacetate derivative of cytochalasin B (4a) showed high lethality in the brine shrimp assay. This is the first occurrence of cytochalasins in Amazonian endophytic fungi from B. guianensis.
Subject(s)
Artemia/drug effects , Aspergillus/chemistry , Cytochalasin B/toxicity , Cytochalasins/toxicity , Endophytes/chemistry , Ergosterol/analogs & derivatives , Fabaceae/microbiology , Mevalonic Acid/analogs & derivatives , Acetylation , Animals , Argentina , Aspergillus/isolation & purification , Cytochalasin B/chemistry , Cytochalasin B/isolation & purification , Cytochalasins/chemistry , Cytochalasins/isolation & purification , Endophytes/isolation & purification , Ergosterol/chemistry , Ergosterol/isolation & purification , Ergosterol/toxicity , Lethal Dose 50 , Mevalonic Acid/chemistry , Mevalonic Acid/isolation & purification , Mevalonic Acid/toxicity , Molecular Structure , Nuclear Magnetic Resonance, Biomolecular , Spectrometry, Mass, Electrospray Ionization , Structure-Activity RelationshipABSTRACT
In this study, we aimed to investigate modulation of glucose uptake by the HTR-8/SVneo human first-trimester extravillous trophoblast cell line by a series of compounds and to study its consequences upon cell proliferation, viability and migration. We observed that uptake of (3)H-deoxy-d-glucose ((3)H-DG; 10 nM) was time-dependent, saturable, inhibited by cytochalasin B (50 and 100 µM), phloretin (0.5 mM) and phloridzin (1 mM), insulin-insensitive and sodium-independent. In the short term (30 min), neither 5-HT (100-1000 µM), melatonin (10 nM) nor the drugs of abuse ethanol (100 mM), nicotine (100 µM), cocaine (25 µM), amphetamine (10-25 µM) and 3,4-methylenedioxy-N-methamphetamine (10 µM) affected (3)H-DG uptake, while dexamethasone (100-1000 µM), fluoxetine (100-300 µM), quercetin, epigallocatechin-3-gallate (30-1000 µM), xanthohumol (XH) and resveratrol (1-500 µM) decreased it. XH was the most potent inhibitor [IC50 = 3.55 (1.37-9.20) µM] of (3)H-DG uptake, behaving as a non-competitive inhibitor of (3)H-DG uptake, both after short- and long-term (24 h) treatment. The effect of XH (5 µM; 24 h) upon (3)H-DG uptake involved mammalian target of rapamycin, tyrosine kinases and c-Jun N-terminal kinases intracellular pathways. Moreover, XH appeared to decrease cellular uptake of lactate due to inhibition of the monocarboxylate transporter 1. Additionally, XH (24 h; 5 µM) decreased cell viability, proliferation, culture growth and migration. The effects of XH upon cell viability and culture growth, but not the antimigratory effect, were mimicked by low extracellular glucose conditions and reversed by high extracellular glucose conditions. We thus suggest that XH, by inhibiting glucose cellular uptake and impairing HTR-8/SVneo cell viability and proliferation, may have a deleterious impact in the process of placentation.
Subject(s)
Deoxyglucose/metabolism , Flavonoids/pharmacology , Glucose Transport Proteins, Facilitative/antagonists & inhibitors , Placentation/drug effects , Propiophenones/pharmacology , Trophoblasts/drug effects , Biological Transport/drug effects , Cell Division/drug effects , Cell Line, Transformed , Cell Movement/drug effects , Cytochalasin B/pharmacology , Cytochalasin B/toxicity , Dexamethasone/pharmacology , Dexamethasone/toxicity , Female , Flavonoids/toxicity , Glucose/pharmacology , Glucose Transport Proteins, Facilitative/physiology , Humans , Illicit Drugs/pharmacology , Illicit Drugs/toxicity , Melatonin/pharmacology , Melatonin/toxicity , Phloretin/pharmacology , Phloretin/toxicity , Phlorhizin/pharmacology , Phlorhizin/toxicity , Polyphenols/pharmacology , Polyphenols/toxicity , Pregnancy , Pregnancy Trimester, First , Propiophenones/toxicity , Protein-Tyrosine Kinases/physiology , Resveratrol , Signal Transduction/drug effects , Stilbenes/pharmacology , Stilbenes/toxicity , TOR Serine-Threonine Kinases/physiology , Trophoblasts/cytologyABSTRACT
Cytoprotective compounds such as amifostine play an important role in chemo- and radiotherapy due to their ability to reduce the side effects of these treatments. Our work was initiated with the intention to design, synthesise and test a new class of heterocyclic compounds that would have an antioxidative profile with the potential to be further developed as cytoprotective agents. The design was based on the privileged tetrahydrobenzazepine scaffold found in many natural products with a wide range of biological properties. This structure was further functionalised with moieties known to possess antioxidative features such as tertiary amine and styrene double bond. A series of eight tetrahydrobenzazepine derivatives of isoquinoline, 3,4-dihydro-ß-carboline and pyridine were synthesised employing the Heck reaction as a key transformation. Some of the prepared compounds were tested for their in vitro effects on chromosome aberrations in peripheral human lymphocytes using the cytochalasin-B blocked micronucleus (MN) assay. Three tetrahydrobenzoazepine derivatives showed significant cytoprotective properties, comparable or even better to those of the radioprotective agent amifostine.
Subject(s)
Antioxidants/chemical synthesis , Antioxidants/pharmacology , Benzazepines/chemical synthesis , Benzazepines/pharmacology , Drug Design , Lymphocytes/drug effects , Micronuclei, Chromosome-Defective/drug effects , Alkylating Agents/toxicity , Amifostine/pharmacology , Cells, Cultured , Cytochalasin B/toxicity , Cytoprotection , Dose-Response Relationship, Drug , Humans , Male , Micronuclei, Chromosome-Defective/chemically induced , Micronucleus Tests , Mitomycin/toxicity , Molecular Structure , Oxidative Stress/drug effects , Radiation-Protective Agents/pharmacology , Structure-Activity RelationshipABSTRACT
The search for micronuclei (MN) in binucleated cells is not always the best choice to recognize microtubule-perturbing agents, as they give rise to (micronucleated) mononucleated cells, mainly via mitotic slippage. We therefore treated peripheral lymphocytes with vincristine (VCR), nocodazole (NOC) and colcemid (COL): (i) to quantify the formation of MN in mononucleated cells and the occurrence of abnormal mitoses (c-anaphases, endoreduplicated or tetraploid metaphases); (ii) to investigate the role of cytokinesis inhibition in determining or modulating the cytogenetic effects induced by the spindle poisons (we used either cytochalasin B (cyt B) or latrunculin A, a cytokinesis inhibitor that acts differently as compared with cyt B); (iii) to assess the ploidy of cells bearing MN by fluorescence in situ hybridisation (FISH) analysis; and (iv) to evaluate the levels of the mitotic arrest deficient (MAD2) protein, that blocks the cell at the metaphase-anaphase transition, by immunoblotting. We observed the induction of numerous abnormal mitoses and tetraploid interphase nuclei, as well as of MN in mononucleated cells, a high percentage of which had a diploid complement. We also found that the effects were generally not dose but chemical dependent, where NOC was proven to be more effective than COL and VCR in inducing overall MN formation and, specifically, diploid micronucleated lymphocytes. Aneugens damaged cells to a greater extent in the presence of cytokinesis inhibitors rather than in their absence. MAD2 protein was expressed in controls to an extent reflecting the amount of lymphocytes which were initially in the G2/M transition phase. The same trend was seen in aneugen-treated cells where MAD2 levels decreased with increasing spindle poison concentration. Here, we demonstrate that micronucleated mononucleated cells and aberrant mitoses can be considered useful markers of exposure to aneugens-like spindle poisons causing preferentially, but not exclusively, mitotic slippage. Assessment of MAD2 levels can be used to confirm the cell-damaging activity of the compounds.
Subject(s)
Aneugens/toxicity , Cytokinesis/drug effects , Lymphocytes/drug effects , Micronucleus Tests/methods , Anaphase/drug effects , Blotting, Western , Bridged Bicyclo Compounds, Heterocyclic/toxicity , Cell Nucleus/drug effects , Cell Proliferation , Cytochalasin B/toxicity , Demecolcine/pharmacology , Humans , In Situ Hybridization, Fluorescence , Metaphase/drug effects , Mitosis/drug effects , Mutagens/toxicity , Nocodazole/pharmacology , Thiazolidines/toxicity , Vincristine/pharmacologyABSTRACT
Mechanical properties of cells have been shown to have a significant role in disease, as in many instances cell stiffness changes when a cell is no longer healthy. We present a high-throughput microfluidics-based approach that exploits the connection between travel time of a cell through a narrow passage and cell stiffness. The system resolves both cell travel time and relative cell diameter while retaining information on the cell level. We show that stiffer cells have longer transit times than less stiff ones and that cell size significantly influences travel times. Experiments with untreated HeLa cells and cells made compliant with latrunculin A and cytochalasin B further demonstrate that travel time is influenced by cell stiffness, with the compliant cells having faster transit time.
Subject(s)
Microfluidics , Bridged Bicyclo Compounds, Heterocyclic/toxicity , Cell Size/drug effects , Cytochalasin B/toxicity , Electrodes , HeLa Cells , Humans , Microfluidics/instrumentation , Thiazolidines/toxicityABSTRACT
Currently, the cosmetics industry relies on the results of in vitro genotoxicity tests to assess the safety of chemicals. Although the cytokinesis-block micronucleus (CBMN) test for the detection of cells that have divided once is routinely used and currently accepted by regulatory agencies, it has some limitations. Reconstituted human epidermis (RHE) is widely used in safety assessments because its physiological properties resemble those of the skin, and because it allows testing of substances such as hydrophobic compounds. Thus, the micronucleus test is being adapted for application in RHE-reconstructed tissues. Here we investigated whether two different reconstructed epidermis models (EPI/001 from Straticell, and RHE/S/17 from Skinethic) are suitable for application of the micronucleus test. We found that acetone does not modify micronucleus frequency, cell viability, and model structure, compared with non-treated RHE. Treatment of the EPI/001 model with mitomycin C and vinblastine resulted in a dose-dependent increase of micronucleus frequency as well as a decrease of tissue viability and of binucleated cell rate, while no changes of the epidermal structure were observed. The number of binucleated cells obtained with the RHE/S/17 model was too small to permit micronucleus testing. These results indicate that the proliferative rate of the tissue used is a critical parameter in performing the micronucleus test on a 3D model.
Subject(s)
Benzhydryl Compounds , Chlorohydrins , Epidermis , Micronucleus Tests/methods , Tissue Engineering , Acetone/pharmacology , Cytochalasin B/toxicity , Epidermis/drug effects , Humans , Mitomycin/toxicity , Tissue Engineering/methods , Vinblastine/toxicityABSTRACT
BRIT1 (BRCT-repeat inhibitor of hTERT expression), also known as microcephalin (MCPH1), is a crucial gene in the complex cellular machine that is devoted to DNA repair and acts as a regulator of both the intra-S and G2/M checkpoints. The most important role of BRIT1/MCPH1 in the regulation of cell cycle progression appears to be the G2/M checkpoint. The K562 and peripheral blood cells of chronic myeloid leukemia (CML) patients at diagnosis were found to downregulate BRIT1/MCPH1. However, we could not find any correlation between bcr/abl activity and the BRIT1/MCPH1 level. In order to study the genomic instability of CML cells, we evaluated the ability of these cells to arrest mitotic division after exposure to hydroxyurea, a known genotoxic agent. We showed that CML cells continue to proliferate without the activation of the G2/M cell cycle checkpoint arrest or of the apoptotic mechanism. This behavior may predispose the cells to accumulate genomic defects. In conclusion, we found that CML cells have a low BRIT1/MCPH1 level and show a defective G2/M arrest, confirming that these cells have a constitutive genomic instability.
Subject(s)
G2 Phase Cell Cycle Checkpoints , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/metabolism , Neoplasm Proteins/metabolism , Nerve Tissue Proteins/metabolism , Actins/antagonists & inhibitors , Adult , Aged , Cell Cycle Proteins , Cell Proliferation/drug effects , Cells, Cultured , Cytochalasin B/toxicity , Cytokinesis/drug effects , Cytoskeletal Proteins , Female , G2 Phase Cell Cycle Checkpoints/drug effects , Gene Expression Regulation, Neoplastic , Genomic Instability , Humans , Hydroxyurea/antagonists & inhibitors , Hydroxyurea/toxicity , K562 Cells , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/blood , Leukocytes/drug effects , Leukocytes/metabolism , Male , Middle Aged , Mutagens/toxicity , Neoplasm Proteins/genetics , Nerve Tissue Proteins/genetics , RNA, Messenger/metabolismABSTRACT
Head and neck squamous cell carcinoma is the fifth most common cancer type worldwide. Even though it is known that the most important environmental aetiological factors for head and neck cancer (HNC) development are tobacco and alcohol, genetic susceptibility is also thought to be important. The use of biomarkers of chromosomal damage due to genetic instability in order to predict risk of cancer as well as to identify high-risk individuals is imperative. We have investigated genetic damage in patients having HNC (n = 59) and their first-degree relatives (FDRs) (n = 34) with a biomarker in two different tissues; the micronucleus (MN) test in peripheral blood lymphocytes and in exfoliated buccal cells. The mean (standard deviation) levels of MN frequencies () in lymphocytes of patients, relatives and controls were 27.10 (9.52), 14.09 (5.13) and 9.00 (6.87), respectively. The mean (standard deviation) levels of MN frequencies () in exfoliated buccal cells of patients, relatives and controls were 2.87 (1.16), 1.38 (0.85) and 1.23 (0.93), respectively. Our results indicated that spontaneous genetic damage in lymphocytes of patients having HNC was significantly higher than that of controls (P < 0.01) and thus genetic instability appeared to exist in lymphocytes of cancer patients. Similar findings were obtained for exfoliated buccal cell MN frequencies of cancer patients (P < 0.01). We observed that the FDRs of patients having HNC showed significantly higher chromosomal damage in terms of MN frequencies in lymphocytes when compared with those of controls (P < 0.05), thus reflecting an increased susceptibility to HNC in FDRs. However, for buccal cell MN frequencies, we could not demonstrate enhanced genetic instability in the FDRs of patients having HNC.
Subject(s)
Epithelial Cells/pathology , Family , Head and Neck Neoplasms/genetics , Head and Neck Neoplasms/pathology , Lymphocytes/pathology , Micronuclei, Chromosome-Defective , Mouth Mucosa/pathology , Adolescent , Adult , Aged , Aged, 80 and over , Child , Cytochalasin B/toxicity , Female , Humans , Male , Micronuclei, Chromosome-Defective/statistics & numerical data , Micronucleus Tests , Middle Aged , Young AdultABSTRACT
The chromosomal aberrations (CA) assay and micronucleus (MN) test were employed to investigate the effect in vitro of zerumbone (ZER) on human chromosomes. ZER is a sesquiterpene compound isolated from the rhizomes of wild ginger, Zingiber zerumbet Smith. The rhizomes of the plant are employed as a traditional medicine for some ailments and as condiments. ZER has been shown to have anti-cancer and apoptosis-inducing properties against various human tumour cells. It has also been shown to be active in vivo against a number of induced malignancies. Studies on ZER genotoxicity in cultured human peripheral blood lymphocytes (PBL) have not been reported so far. Therefore, the present study was undertaken to investigate the ability of ZER to induce chromosomal aberrations and micronuclei formation in human lymphocytes in vitro. Human blood samples were obtained from four healthy, non-smoking males aged 25-35years. Cultures were exposed to the drug for 48h at four final concentrations: 10, 20, 40 and 80 microM. Mitomycin C (MMC) was used as a positive control. The results of chromosomal aberrations assay showed that ZER was not clastogenic, when compared to untreated control, meanwhile MN test results showed a dose-dependent increase in MN formation. The overall clastogenic effect of ZER on human PBL was statistically not significant. In conclusion, ZER is a cytotoxic but not a clastogenic substance in human PBL.
Subject(s)
Lymphocytes/drug effects , Mutagens , Sesquiterpenes/toxicity , Adult , Cell Cycle/drug effects , Cell Proliferation/drug effects , Cells, Cultured , Chromosome Aberrations/drug effects , Cytochalasin B/antagonists & inhibitors , Cytochalasin B/toxicity , Zingiber officinale/chemistry , Humans , Male , Micronucleus Tests , Mitomycin/toxicity , Mitotic Index , Mutagenicity Tests , Nucleic Acid Synthesis Inhibitors/toxicity , Plant Roots/chemistry , Sesquiterpenes/isolation & purification , Young AdultABSTRACT
The mechanical properties of cells are important for many cellular processes. Here, atomic force microscopy (AFM) and laser scanning confocal microscopy (LSCM) were carried out to characterize lymphocyte and Jurkat cells. The average elastic modulus of lymphocyte is 1.24 +/- 0.09 kPa, which is almost twofold higher than that of Jurkat cell (0.51 +/- 0.06 kPa). LSCM images of sub-membrane cytoskeleton showed a significant difference in the organization of their F-actin structures. Lymphocyte cells had more and thicker actin bundles than that of Jurkat cells. Lymphocyte and Jurkat cells after adding the F-actin destabilizing agent Cytochalasin-B (Cyt-B) were also investigated by AFM. A decrease in the elastic modulus of lymphocyte from a value of 1.24 +/- 0.09 kPa down to 0.34 +/- 0.04 kPa for 24 h was observed, and that of Jurkat cell decreased from 0.51 +/- 0.06 kPa to 0.23 +/- 0.04 kPa. We really believe that this technology will be used for cancer detection and opens a door to study the biophysical properties of signaling domains extending from the cell surface to deeper parts of the cell.
Subject(s)
Cytoskeleton/metabolism , Lymphocytes/physiology , Biomechanical Phenomena , Cell Line, Tumor , Cells, Cultured , Cytochalasin B/toxicity , Cytoskeleton/drug effects , Humans , Microscopy, Atomic Force , Microscopy, ConfocalABSTRACT
In vitro assessment of cytotoxicity based on electrochemical impedance spectroscopy (EIS) needs more quantitative methods to analyze the alteration of cell morphology and motility, and hence the potential risk to human health. Here, we applied electric cell-substrate impedance sensing (ECIS) to evaluate dose-dependent responses of human umbilical vein endothelial cells exposed to cytochalasin B. To detect subtle changes in cell morphology, the frequency-dependent impedance data of the cell monolayer were measured and analyzed with a theoretical cell-electrode model. To detect the alternation of cell micromotion in response to cytochalasin B challenge, time-series impedance fluctuations of cell-covered electrodes were monitored and the values of power spectrum, variance, and variance of the increments were calculated to verify the difference. While a dose-dependent relationship was generally observed from the overall resistance of the cell monolayer, the analysis of frequency-dependent impedance and impedance fluctuations distinguished cytochalasin B levels as low as 0.1 microM. Our results show that cytochalasin B causes a decrease of junctional resistance between cells, an increase of membrane capacitance, and the reduction in micromotion.
Subject(s)
Apoptosis/drug effects , Biological Assay/instrumentation , Cytochalasin B/toxicity , Electrochemistry/instrumentation , Endothelial Cells/drug effects , Endothelial Cells/physiology , Toxicity Tests/instrumentation , Biosensing Techniques/instrumentation , Cells, Cultured , Dose-Response Relationship, Drug , Electric Impedance , Equipment Design , Equipment Failure Analysis , Humans , Plethysmography, Impedance/instrumentation , Plethysmography, Impedance/methods , Reproducibility of Results , Sensitivity and SpecificityABSTRACT
The study of DNA damage at the chromosome level is an essential part of genetic toxicology because chromosomal mutation is an important event in carcinogenesis. Micronucleus assays have emerged as one of the preferred methods for assessing chromosome damage because they enable both chromosome loss and chromosome breakage to be measured reliably. Because micronuclei can only be expressed in cells that complete nuclear, division a special method was developed that identifies such cells by their binucleate appearance when blocked from performing cytokinesis by cytochalasin-B, a microfilament-assembly inhibitor. The cytokinesis-block micronucleus (CBMN) assay allows better precision because the data obtained are not confounded by altered cell division kinetics caused by cytotoxicity of agents tested or suboptimal cell culture conditions. The method is now applied to various cell types for population monitoring of genetic damage, screening of chemicals for genotoxic potential and for specific purposes such as the prediction of the radiosensitivity of tumors and the interindividual variation in radiosensitivity. In its current basic form the CBMN assay can provide, using simple morphological criteria, the following measures of genotoxicity and cytotoxicity: chromosome breakage, chromosome loss, chromosome rearrangement (nucleoplasmic bridges), gene amplification (nuclear buds), cell division inhibition, necrosis and apoptosis. The cytosine arabinoside modification of the CBMN assay allows for measurement of excision repairable lesions. The use of molecular probes enables chromosome loss to be distinguished from chromosome breakage and importantly nondisjunction in nonmicronucleated binucleated cells can be efficiently measured. The CBMN technique therefore provides multiple and complementary measures of genotoxicity and cytotoxicity which can be achieved with relative ease within one system. The basic principles and methods (including detailed scoring criteria for all the genotoxicity and cytotoxicity end points) of the CBMN assay are described and areas for future development identified.
Subject(s)
Chromosome Aberrations , Cytokinesis/genetics , Animals , Cytochalasin B/toxicity , Cytokinesis/drug effects , DNA Damage , Micronucleus Tests/methods , Models, Biological , Reproducibility of ResultsABSTRACT
To meet the requirements of the EU 7th Amendment to the Cosmetics Directive, manufacturers of cosmetics products will need to ascertain the safety of ingredients using non-animal methods. Starting in 2009, in vivo genotoxicity tests for cosmetics ingredients will not be allowed. Skin is a target area of interest for many cosmetic products because of its relatively high exposure. Therefore, it would be beneficial to have a non-animal, skin-based genotoxicity assay, especially one that utilized human skin in vitro. In this paper, we describe the development of a reproducible micronucleus assay that uses EpiDerm engineered human skin constructs (MatTek Corp., Ashland, MA). We describe methods for isolating single cells from the 3D skin model and for processing the cells for microscopic analysis of micronuclei (MN). In addition, since little was known about the kinetics of the dividing keratinocytes in the EpiDerm model, we evaluated whether cytochalasin B (Cyt-B) could be used to distinguish the population of dividing cells allowing the development of a micronucleus assay in binucleated cells. We found that the frequency of binucleated cells increased both with time and with increasing concentration of Cyt-B. After a 48-h exposure, 30-50% binucleated cells were reproducibly obtained. Finally, we evaluated micronucleus induction using the model genotoxicants mitomycin C (MMC) and vinblastine sulfate (VB). The background frequency of MN is very low and reproducible in this model, and statistically significant increases in the frequency of micronucleated cells were induced by both MMC and VB. These are initial steps in developing a routine "in vivo-like" assay for chromosomal damage in human tissue. It is hoped that other investigators utilize these methods to further the understanding of this potentially valuable new non-animal method.
Subject(s)
Cell Nucleus/drug effects , Mutagenicity Tests/methods , Mutagens/toxicity , Skin, Artificial , Cell Division/drug effects , Cells, Cultured , Coculture Techniques , Cytochalasin B/toxicity , Dose-Response Relationship, Drug , Epidermis/drug effects , Epidermis/metabolism , Epidermis/pathology , Evaluation Studies as Topic , Humans , Imaging, Three-Dimensional , Keratinocytes/drug effects , Kinetics , Micronucleus Tests , Mitomycin/toxicity , Models, Biological , Reproducibility of Results , Time Factors , Vinblastine/toxicityABSTRACT
The aim of this study was to evaluate the effect of cytochalasin B (CCB) pre-treatment before vitrification on ability of immature oocytes from lamb ovaries to progress until metaphase II (MII) stage after vitrification/warming procedure. Cumulus-oocyte complexes (COCs) were obtained from ovaries of lambs, from 80 to 90 days old, collected from a local slaughterhouse. Before vitrification, COCs were randomly distributed in two experimental groups corresponding to the incubation with or without 7.5 microg/ml CCB for 30 min. In order to study cryoprotectant and CCB pre-treatment toxicity (toxicity test), oocytes were exposed to cryoprotectants, with or without CCB pre-treatment, but without plunging into N2 liquid. Vitrification solution was composed by 4.48 M EG plus 3.50 M DMSO supplemented with 0.25 M sucrose. Two-step addition was performed. After vitrification or toxicity test, COCs were matured in bicarbonate-buffered TCM 199 containing 10% foetal calf serum and 10 ng/ml epidermal growth factor. A sample of COCs was directly in vitro matured (control group). Rates of MII oocytes of toxicity groups both, with or without CCB pre-treatment were lower than control group (41.1-50.0 versus 79.9, respectively; P<0.05). After vitrification, a lower number of oocytes progressed to MII stage in comparison with non-vitrification groups (P<0.05). In vitrified groups both with or without CCB pre-treatment 8.0 and 12.7%, respectively, of immature oocytes reached MII stage by the end of in vitro maturation culture. No effect of CCB was observed, either in the toxicity or vitrified groups. In conclusion, no effect of CCB pre-treatment before vitrification was detected in this study with immature oocytes of pre-pubertal sheep. More studies are needed in order to increase ovine oocyte survival after vitrification.
Subject(s)
Cryopreservation/veterinary , Cytochalasin B/pharmacology , Metaphase/drug effects , Oocytes/cytology , Sheep/physiology , Animals , Animals, Newborn , Cell Survival , Cryopreservation/methods , Cryoprotective Agents/pharmacology , Cytochalasin B/toxicity , Female , Oocytes/growth & development , Toxicity Tests/veterinaryABSTRACT
Thimerosal is a widely used preservative in health care products, especially in vaccines. Due to possible adverse health effects, investigations on its metabolism and toxicity are urgently needed. An in vivo study on chronic toxicity of thimerosal in rats was inconclusive and reports on genotoxic effects in various in vitro systems were contradictory. Therefore, we reinvestigated thimerosal in the cytochalasin B block micronucleus test. Glutathione S-transferases were proposed to be involved in the detoxification of thimerosal or its decomposition products. Since the outcome of genotoxicity studies can be dependent on the metabolic competence of the cells used, we were additionally interested whether polymorphisms of glutathione S-transferases (GSTM1, GSTT1, or GSTP1) may influence the results of the micronucleus test with primary human lymphocytes. Blood samples of six healthy donors of different glutathione S-transferase genotypes were included in the study. At least two independent experiments were performed for each blood donor. Significant induction of micronuclei was seen at concentrations between 0.05-0.5 micro g/ml in 14 out of 16 experiments. Thus, genotoxic effects were seen even at concentrations which can occur at the injection site. Toxicity and toxicity-related elevation of micronuclei was seen at and above 0.6 micro g/ml thimerosal. Marked individual and intraindividual variations in the in vitro response to thimerosal among the different blood donors occurred. However, there was no association observed with any of the glutathione S-transferase polymorphism investigated. In conclusion, thimerosal is genotoxic in the cytochalasin B block micronucleus test with human lymphocytes. These data raise some concern on the widespread use of thimerosal.
Subject(s)
Cytochalasin B/toxicity , Lymphocytes/drug effects , Micronucleus Tests/methods , Mutagens/toxicity , Preservatives, Pharmaceutical/toxicity , Thimerosal/toxicity , Actin Cytoskeleton/drug effects , Cell Division/drug effects , Dose-Response Relationship, Drug , Drug Antagonism , Genotype , Glutathione Transferase/blood , Glutathione Transferase/classification , Glutathione Transferase/genetics , Humans , Lymphocytes/enzymology , Polymorphism, GeneticABSTRACT
The in vitro micronucleus test is currently used as a screening assay during the early stages of drug development by pharmaceutical companies to identify chemicals likely to produce positive outcomes in the in vitro chromosome aberration assay. For several reasons the assay is being considered as an alternative to the aberration assay-it requires less laboratory time, less material and less training. However, the current screening protocols are not rigorous enough to fully satisfy concerns about genotoxic safety. Using a protocol previously developed by testing 16 chemicals, this manuscript contributes to the validation of the protocol using 10 additional chemicals. Furthermore, conclusions drawn from the developmental effort regarding the need for an extended exposure in the absence of metabolic activation, the number of cells to be counted, and the preferred statistical procedure for the assay are re-examined. The recommended, validated protocol utilizes cytochalasin B and 4h exposures in the presence and in the absence of metabolic activation, specifies the need to test to a relative survival rate of approximately 50%, requires the counting of 2,000 binucleated cells per treatment concentration, and employs a trend test for statistical analysis of the data.
Subject(s)
Micronucleus Tests/methods , Micronucleus Tests/standards , Animals , CHO Cells , Cell Division/drug effects , Cell Division/genetics , Cricetinae , Cricetulus , Cytochalasin B/toxicity , Data Interpretation, Statistical , Dose-Response Relationship, Drug , Mutagens/toxicityABSTRACT
In the present study, we report the results of an investigation on pyrrolizidine alkaloids extracted from Senecio brasiliensis (Sprengel) Less., which were stored for more than 23 years under variable conditions of temperature and humidity and exposed to light. Both the crude alkaloid (integerrimine+retrorsine+impurities) and pure integerrimine conserved the ability to induce acute toxicity in mice, leading to the death of the animals in less than 24h. The alkaloids also conserved the potential to induce significant increases in micronucleus frequencies in polychromatic erythrocytes of mouse bone marrow compared to the negative control. The administration of alkaloids to lymphocyte cultures blocked with cytochalasin-B showed no significant increase in micronucleus frequency in binucleated cells, probably due to the lack of a metabolic activation mechanism. However, an antimitotic effect was observed.